Allergic reactions to oxaliplatin therapy - An overview

European Journal of Oncology Pharmacy

Volumn 2, Issue 2, 2008, Pages 27-28

  Köhlmoos, Carolin ^a   Marquardt, Goentje Gesine ^a   Brinkmann, Detlev ^a   Meier, Klaus ^a  

^a Heidekreis Clinics   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IMMUNOGLOBULIN E; OXALIPLATIN;

ADULT; AGED; ANAPHYLAXIS; CASE REPORT; COLORECTAL CANCER; DESENSITIZATION; DRUG HYPERSENSITIVITY; DRUG INFUSION; DYSPNEA; ERYTHEMA; FEMALE; FEVER; HUMAN; MALE; PRURITUS; RASH; RISK BENEFIT ANALYSIS; SHORT SURVEY;

EID: 77953379642     PISSN: 17833914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (14)

1. ABDA Database, accessed 22.11.2006.
2. Eloxantin SPC, Sanofi-Aventis, September 2004.
3. Saif MW. Hypersensitivity reactions associated with oxaliplatin. Expert Opin Drug Saf. 2006;5(5):687-694
4. Siu SWK, Chan RTT, et al. Hypersensitivity reactions to oxaliplatin: experience in a single institute. Ann Oncol. 2006;17:259-261 (Pubitemid 43160115)
5. Hewitt MR, Sun W: Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management. Clin Colorectal Canc. 2006;6(2):114-117 (Pubitemid 44445745)
6. Santini D, Tonini G, et al. Idiosyncratic reaction after oxaliplatin infusion. Ann Oncol. 2001;21(1):132-133
7. Thomas R, Quinn M, et al. Hypersensitivity and idiosyncratic reactions to oxaliplatin. Cancer. 2003;97(9):2301-2307
8. Gowda A, Goel R, et al. Hypersensitivity Reactions to oxaliplatin: incidence and management. Oncology (Williston Park). 2004;18(13):1671-5; Discussion 1676, 1680, 1683-1684
9. de Vries RS, Mattijssen EJ, et al. Serious delayed hypersensitivity reaction to oxaliplatin. Ann Oncol. 2006;17(11):1723-1733
10. Edmondson D, Gruling BJ, et al. Oxaliplatin hypersensitivity: case report and successful repeat desentization. Am J Therapeutics. 2007;14(1):116-118 (Pubitemid 46278673)
11. Castells M: Rapid desensitization for hypersensitivity to chemotherapy agents. Curr Opin Allergy Clin Immunol. 2006;6(4):271-277
12. Gammon D, Bhargava P, et al: Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol. Oncologist. 2004;9(5):546-549 (Pubitemid 39332318)
13. Junker A. Klinische Untersuchungen zu Dosis-Konzentrations- Effektbeziehungen von Oxaliplatin. Dissertation 2006.
14. Massari C, Brienza S, et al. Pharmacokinetics of oxaliplatin in patients with normal versus impaired renal function. Cancer Chemother Pharmacol. 2000;45(2):157-164 (Pubitemid 30090247)